NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Meril Life Sciences

Meril Life Sciences

Private
VapiHealthcare & Life Scienceshttps://www.merillife.com/

Last Round

Private Equity

Jul 21, 2025

Est. Valuation

$6.6B

Total Funding Raised

$453M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Meril Life Sciences is a medical device company that designs, manufactures, and distributes clinically relevant devices for vascular intervention, orthopedics, in-vitro diagnostics, and endo-surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

medical devicestranscatheter aortic valve replacementTAVRcoronary stentorthopedic implantssurgical roboticsmedtechin-vitro diagnosticsIVDvascular interventionsurgical staplersminimally invasive surgeryrobotic surgeryinterventional cardiologyjoint replacement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Meril Life Sciences Comps

Public and private peers based on sector, stage, and business model.

Meril Life Sciences comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Meril Life Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJul 21, 2025
Private EquityFeb 22, 2022

Key People

Founding team and executive leadership

Vivek Shah

Chief Executive Officer

Executive Team

Sumit Kumar

Chief Technology Officer

Executive Team

Meril Life Sciences Investors

Notable investors and investment history

Meril Life Sciences investors
InvestorRounds
Anchorage Capital PartnersPrivate Equity
Anchorage Capital PartnersPrivate Equity
Warburg PincusPrivate Equity
Abu Dhabi Investment AuthorityPrivate Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 21, 2025

    $200M round led by Abu Dhabi Investment Authority.

  • May 1, 2025

    Monthly visitors grew 36% MoM, reaching 77.5K.

Meril Life Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Meril Life Sciences Filings

SEC and related filings with document metadata.

Appears On

Curated lists and screens where this company is featured.

Frequently Asked Questions

Common questions about Meril Life Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersVapi
Employee Range6,890
Year Founded2006
Last FundingJul 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.